Clinical trials: Inoperable Hepatocellular Carcinoma
Liver Cancer
Tamoxifen in Treating Patients With Primary Liver Cancer
RATIONALE: Estrogen can stimulate the growth of cancer cells. Hormone therapy using tamoxifen may fight liver cancer by blocking the absorption of estrogen.
- Trial name
- NCT00003424
- Testing
- tamoxifen citrate
- Where
- 8 sites in Hong Kong, Indonesia and 4 more
- Volunteers
- 300 people
- Sponsor
- National Medical Research Council (NMRC), Singapore